When we published the Cerebrum article, “The Brain Games Conundrum: Does Cognitive Function Really Sharpen the Mind?”, and a follow-up Q&A with the authors in November 2014, three aspects of the article were crystal clear: I) Few topics in neuroscience evoke as much debate as brain game effectiveness. 2) Advertising has convinced tens of thousands of people to open their wallets and buy products. 3) The science surrounding the benefits of brain games is sketchy at best.
The article was in direct contrast to website claims by Lumosity, a major player in the brain-game business, with more than $1 billion a year in revenues and 60-million members. At the time, Lumosity’s website boasted of nine peer-reviewed studies, 36 university collaborators, and testimonials galore.
Now, according to the Federal Trade Commission (FTA):
The creators and marketers of the Lumosity ‘brain training’ program have agreed to settle FTA charges alleging that they deceived consumers with unfounded claims that Lumosity games can help users perform better at work and in school, and reduce or delay cognitive impairment associated with age and other serious health conditions.
As part of the settlement, Lumos Labs, the company behind Lumosity, will pay $2 million in redress and will notify subscribers of the FTC action and provide them with an easy way to cancel their auto-renewal to avoid future billing.